The new profile of drug-resistant tuberculosis in Russia : a global and local perspective : summary of a joint workshop by the Institute of Medicine and the Russian Academy of Medical Science / Steve Olsen, Rebecca English, and Anne Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies and Russian Academy of Medical Sciences.

Contributor(s):

Material type: Text

TextSeries: Online access: National Academy of Sciences National Academies Press | Online access: NCBI NCBI BookshelfPublication details: Washington, D.C. : National Academies Press, ©2011.Description: 1 online resource (xviii, 139 pages) : illustrations (some color)Content type:

text

Media type:

computer

Carrier type:

online resource

ISBN:

9780309162982
030916298X
1283213354
9781283213356
9786613213358
6613213357

Subject(s): Genre/Form:

Additional physical formats: Print version:: New profile of drug-resistant tuberculosis in Russia.DDC classification:

614.542 23

LOC classification:

RA644.T7 N39 2011eb

NLM classification:

WF 200

Online resources:

Click here to access online

Contents:

Introduction -- A global perspective on drug-resistant tuberculosis -- Drug-resistant tuberculosis in the Russian Federation -- Transmission and infection control of drug-resistant TB -- Diagnosis of drug-resistant TB -- Treatment of drug-resistant TB -- TB and drug-resistant TB in vulnerable populations -- The second-line drug supply chain -- The development of new TB diagnostics and drugs -- Convergence of science and policy to create a call for action.

Summary: An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also a disease of poverty--the vast majority of tuberculosis deaths occur in the developing world. Exacerbating the devastation caused by TB is the growing threat of drug-resistant forms of the disease in many parts of the world. Drug-resistant tuberculosis presents a number of significant challenges in terms of controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of these strains of TB, resistant to standard antibiotic treatment, has been exacerbated by the occurrence of social, political, and economic upheavals. The Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences held a workshop to discuss ways to fight the growing threat of drug-resistant TB. This book presents information from experts on the nature of this threat and how it can be addressed by exploring various treatment and diagnostic options.

Item type:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Home library	Collection	Call number	Materials specified	Status	Date due	Barcode
Electronic-Books	OPJGU Sonepat- Campus	E-Books EBSCO			Available

Includes bibliographical references (pages 109-111).

An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also a disease of poverty--the vast majority of tuberculosis deaths occur in the developing world. Exacerbating the devastation caused by TB is the growing threat of drug-resistant forms of the disease in many parts of the world. Drug-resistant tuberculosis presents a number of significant challenges in terms of controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of these strains of TB, resistant to standard antibiotic treatment, has been exacerbated by the occurrence of social, political, and economic upheavals. The Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences held a workshop to discuss ways to fight the growing threat of drug-resistant TB. This book presents information from experts on the nature of this threat and how it can be addressed by exploring various treatment and diagnostic options.